Efficient in vitro gene delivery by hybrid biopolymer/virus nanobiovectors

Journal of Controlled Release

Volumn 192, Issue , 2014, Pages 40-46

  Keswani, Rahul ^a   Su, Kai ^b,c   Pack, Daniel W ^a,b,c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Chitosan; Gene delivery; Gene therapy; Hybrid vectors; Retrovirus

Indexed keywords

BIOCOMPATIBILITY; CHITOSAN; GENE EXPRESSION; GENE THERAPY; ONCOGENIC VIRUSES; VECTORS;

GENE DELIVERY; GENE DELIVERY AGENTS; HYBRID VECTORS; RECOMBINANT RETROVIRUS; RETROVIRUS; TRANSGENE EXPRESSION; VIRAL ENVELOPE PROTEINS; VIRUS-LIKE PARTICLES; IN-VITRO;

GENE TRANSFER; CHITOSAN;

BIOMATERIAL; BIOPOLYMER; CHITOSAN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS NANOBIOVECTOR; VIRUS VECTOR; NANOBIOVECTOR; RETROVIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; MURINE LEUKEMIA VIRUS; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; STATIC ELECTRICITY; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS LIKE AGENT; BIOCOMPATIBILITY; CHEMICAL COMPOSITION; COMPLEX FORMATION; CYTOTOXICITY TEST; EMBRYO; GENE TARGETING; HYDRODYNAMICS; IN VITRO STUDY; LIGHT SCATTERING; PHYSICAL CHEMISTRY; SPACE; STOICHIOMETRY; ZETA POTENTIAL; CHEMISTRY; GENETICS; HEK293 CELL LINE; PROCEDURES; ULTRASTRUCTURE; VIRION;

CHITOSAN; GENETIC VECTORS; HEK293 CELLS; HUMANS; LEUKEMIA VIRUS, MURINE; TRANSFECTION; VIRION;

EID: 84904580150     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.06.060     Document Type: Article

References (36)

1. T. Friedmann, and R. Roblin Gene therapy for human genetic disease? Science 175 1972 949 955
2. E.W. Alton, D.M. Geddes, D.R. Gill, C.F. Higgins, S.C. Hyde, J.A. Innes, and D.J. Porteous Towards gene therapy for cystic fibrosis: a clinical progress report Gene Ther. 5 1998 291 292
3. E. Alton Progress and prospects: gene therapy clinical trials (part 1) Gene Ther. 14 2007 1439 1447 (Pubitemid 47500647)
4. K. Inui, S. Okada, and G. Dickson Gene therapy in duchenne muscular dystrophy Brain Dev. 18 1996 357 361 (Pubitemid 26336371)
5. G.L. Odom, P. Gregorevic, and J.S. Chamberlain Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances Biochim. Biophys. Acta 1772 2007 243 262 (Pubitemid 46123917)
6. E. Galanis, and S. Russell Cancer gene therapy clinical trials: lessons for the future Br. J. Cancer 85 2001 1432 1436 (Pubitemid 34001569)
7. U. Griesenbach Progress and prospects: gene therapy clinical trials (part 2) Gene Ther. 14 2007 1555 1563 (Pubitemid 350056227)
8. M. McCarthy Gene therapy applied to treatment of hiv-1 infection Lancet 351 1998 1709
9. I.M. Verma, and N. Somia Gene therapy - promises, problems and prospects Nature 389 1997 239 242 (Pubitemid 27406627)
10. D.W. Pack, A.S. Hoffman, S. Pun, and P.S. Stayton Design and development of polymers for gene delivery Nat. Rev. Drug Discov. 4 2005 581 593 (Pubitemid 40975711)
11. D.S. Anson The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery Genet. Vaccines Ther. 2 2004 9
12. Y. Yi, J.J. Noh, and K.H. Lee Current advances in retroviral gene therapy Curr. Genet. Ther. 11 2011 218 228
13. P. Erbacher, M.T. Bousser, J. Raimond, M. Monsigny, P. Midoux, and A.C. Roche Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages Hum. Gene Ther. 7 1996 721 729 (Pubitemid 26125842)
14. W.T. Godbey, K.K. Wu, and A.G. Mikos Poly(ethylenimine) and its role in gene delivery J. Control. Release 60 1999 149 160 (Pubitemid 29335941)
15. Hui Zhong, Z.-G. He, Zheng Li, G.-Y. Li, S.-R. Shen, and X.-L. Li Studies on polyamidoamine dendrimers as efficient gene delivery vector J. Biomater. Appl. 22 2008 527 544 (Pubitemid 351597406)
16. A. Cao, D. Briane, and R. Coudert Chapter 5: cationic liposomes as transmembrane carriers of nucleic acids A.L. Liu, Advances in Planar Lipid Bilayers and Liposomes 2006 Academic Press 135 190 (Pubitemid 351981961)
17. J. Mairhofer, and R. Grabherr Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA Mol. Biotechnol. 39 2008 97 104
18. S. Li, and L. Huang Nonviral gene therapy: promises and challenges Gene Ther. 7 2000 31 34 (Pubitemid 30077146)
19. H.N. Vu, J.D. Ramsey, and D.W. Pack Engineering of a stable retroviral gene delivery vector by directed evolution Mol. Ther. 16 2008 308 314 (Pubitemid 351168040)
20. J. Ramseys Hybrid Gene Therapy Vectors Comprised of Synthetic Polymer and Noninfectious Virus-like Particles (Ph.D. Thesis) 2006 University of Illinois Urbana-Champaign
21. J.D. Ramsey, H.N. Vu, and D.W. Pack Top down approach for construction of hybrid polymer-virus gene delivery vectors J. Control. Release 144 2010 39 45
22. S. Sharma, F. Murai, A. Miyanohara, and T. Friedmann Noninfectious virus-like particles produced by moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents Proc. Natl. Acad. Sci. U. S. A. 94 1997 10803 10808 (Pubitemid 27430815)
23. D.M. Drake, R.K. Keswani, and D.W. Pack Effect of serum on transfection by polyethylenimine/virus-like particle hybrid gene delivery vectors Pharm. Res. 11 2010 2457 2465
24. R.K. Keswani, I.M. Pozdol, and D.W. Pack Design of hybrid lipid/retroviral-like particle gene delivery vectors Mol. Pharm. 10 2013 1725 1735
25. Y.G. Kuznetsov, A. Low, H. Fan, and A. McPherson Atomic force microscopy investigation of wild-type moloney murine leukemia virus particles and virus particles lacking the envelope protein Virology 323 2004 189 196 (Pubitemid 38748467)
26. M. Huang, C.-W. Fong, E. Khor, and L.-Y. Lim Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation J. Control. Release 106 2005 391 406 (Pubitemid 41187448)
27. M. Huang, E. Khor, and L.-Y. Lim Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation Pharm. Res. 21 2004 344 353 (Pubitemid 38221982)
28. I.A. Khalil, K. Kogure, H. Akita, and H. Harashima Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery Pharmacol. Rev. 58 2006 32 45
29. C. Pichon, L. Billiet, and P. Midoux Chemical vectors for gene delivery: uptake and intracellular trafficking Curr. Opin. Biotechnol. 21 2010 640 645
30. J.L. Anderson, and T.J. Hope Intracellular trafficking of retroviral vectors: obstacles and advances Gene Ther. 12 2005 1667 1678 (Pubitemid 41679170)
31. T. Aoki, R. Nomura, and T. Fujimoto Tyrosine phosphorylation of caveolin-1 in the endothelium Exp. Cell Res. 253 1999 629 636 (Pubitemid 30003124)
32. A. Akinc, M. Thomas, A.M. Klibanov, and R. Langer Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis J. Gene Med. 7 2005 657 663 (Pubitemid 40744532)
33. C. Beer, D.S. Andersen, A. Rojek, and L. Pedersen Caveola-dependent endocytic entry of amphotropic murine leukemia virus J. Virol. 79 2005 10776 10787 (Pubitemid 41098616)
34. J.-H. Jang, D.V. Schaffer, and L.D. Shea Engineering biomaterial systems to enhance viral vector gene delivery Mol. Ther. 19 2011 1407 1415
35. T. Wilson, D. Papahadjopoulos, and R. Taber Biological properties of poliovirus encapsulated in lipid vesicles: Antibody resistance and infectivity in virus-resistant cells Proc. Natl. Acad. Sci. U. S. A. 74 1977 3471 3475 (Pubitemid 8177799)
36. C. Yoshihara, K. Hamada, and Y. Koyama Preparation of a novel adenovirus formulation with artificial envelope of multilayer polymer-coatings: therapeutic effect on metastatic ovarian cancer Oncol. Rep. 23 2010 733 738